Cirrhotic rat liver: reference to transporter activity and morphologic changes in bile canaliculi--gadoxetic acid-enhanced MR imaging.
about
Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlationAssessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRIQuantitative Measurement of Hepatic Fibrosis with Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients with Chronic Hepatitis B Infection: A Comparative Study on Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis-4 Index.Quantitative evaluation of enhancement patterns in focal solid liver lesions with Gd-EOB-DTPA-enhanced MRI.Effect of change in transporter expression on gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging during hepatocarcinogenesis in rats.Histogram analysis of gadoxetic acid-enhanced MRI for quantitative hepatic fibrosis measurementGadoxetic acid-enhanced MRI and sonoelastography: non-invasive assessments of chemoprevention of liver fibrosis in thioacetamide-induced rats with Sho-Saiko-To.CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.Consensus report of the 4th International Forum for Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid Magnetic Resonance ImagingGadoxetate Acid-Enhanced MR Imaging for HCC: A Review for Clinicians.Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Gd-EOB-DTPA for the Evaluation of Liver Fibrosis Induced by Carbon Tetrachloride in RatsNovel Imaging Diagnosis for Hepatocellular Carcinoma: Consensus from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014)Disodium gadoxetate uptake in progressive familial intrahepatic cholestasis type I: Enhancing our understanding of the cholestatic disease.Use of gadoxetate disodium for functional MRI based on its unique molecular mechanism.Combining hyperpolarized 13 C MRI with a liver-specific gadolinium contrast agent for selective assessment of hepatocyte metabolism.Curcumin prevents bile canalicular alterations in the liver of hamsters infected with Opisthorchis viverrini.Quantitative Assessment of Liver Function Using Gadoxetate-Enhanced Magnetic Resonance Imaging: Monitoring Transporter-Mediated Processes in Healthy Volunteers.Gd-EOB-DTPA-enhanced MR relaxometry for the detection and staging of liver fibrosis.Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients.Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images.Diagnostic imaging of hepatocellular carcinoma: recent progress.Effect of lapatinib on hepatic parenchymal enhancement on gadoxetate disodium (EOB)-enhanced MRI scans of the rat liver.Consensus report from the 6th International forum for liver MRI using gadoxetic acid.Gadoxetic acid: pearls and pitfalls.Pre-Hepatectomy Assessment of Bile Transporter Expression by Gadoxetic Acid-Enhanced MRI in a Rat Model of Liver Cirrhosis.Appearance of hepatocellular carcinoma on gadoxetic acid-enhanced hepato-biliary phase MR imaging: a systematic review.Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?Simultaneous PET/MR body imaging in rats: initial experiences with an integrated PET/MRI scanner.Age dependence of spleen- and muscle-corrected hepatic signal enhancement on hepatobiliary phase gadoxetate MRI.Quantitative assessment of hepatic function: modified look-locker inversion recovery (MOLLI) sequence for T1 mapping on Gd-EOB-DTPA-enhanced liver MR imaging.Staging liver fibrosis in chronic hepatitis B with T1 relaxation time index on gadoxetic acid-enhanced MRI: Comparison with aspartate aminotransferase-to-platelet ratio index and FIB-4.Hepatic enhancement of Gd-EOB-DTPA-enhanced 3 Tesla MR imaging: Assessing severity of liver cirrhosis.The diagnostic efficacy of quantitative liver MR imaging with diffusion-weighted, SWI, and hepato-specific contrast-enhanced sequences in staging liver fibrosis--a multiparametric approach.Relationship between severity of liver dysfunction and the relative ratio of liver to aortic enhancement (RE) on MRI using hepatocyte-specific contrast.Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging as a useful detection method for advanced primary biliary cirrhosis.Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging.cDNA Microarray Analysis and Influx Transporter OATP1B1 in Liver Cells After Exposure to Gadoxetate Disodium, a Gadolinium-based Contrast Agent in MRI Liver Imaging.Hepatocellular carcinoma in a North American population: Does hepatobiliary MR imaging with Gd-EOB-DTPA improve sensitivity and confidence for diagnosis?Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla
P2860
Q30359290-D80187CC-2294-45BA-BA04-31FDC5971273Q30444857-6944CC74-896A-4BC0-82B8-28EFD0A2EEB3Q33561380-52E4283F-C266-441B-A4BC-750CB27781DBQ33784125-4A51D0B1-C28D-44AF-B43C-4C6B9F0B9279Q33823977-E6D158B5-57B0-4065-8EBF-258E6A224407Q34612486-7047D672-2770-42DF-97E0-06D1388BECA0Q34663436-6C453BCD-FC21-4FD3-B74E-688551EBFACBQ34681076-5D1CD4BD-92B9-4C16-893E-4C4DFCD98E79Q35148664-3274BEC9-D82E-483F-9483-13A00E69D974Q35207733-6E3E7135-6C81-4D0E-8D84-3C29AEED904AQ35664034-C3BAC137-C6F8-45B5-9E02-C43160F410AAQ36423114-F4645981-BC30-4AA5-B988-20497E01B63DQ36987409-AEE85555-D3DC-43CC-9240-D03C8EE7801CQ37175669-5AD861CB-8739-4818-B68F-1BA3A562F263Q37503563-4A56BE83-FC02-4548-8BB7-2ECAE58FE7E1Q37563189-256D04D1-6504-4ACB-88DB-38C0F6E8FDE8Q37582508-ECCD712F-8D5C-4376-A5D4-EAF563197037Q37609582-5D017437-6980-43BE-9086-06F4CA06E7B2Q37924180-FDFAFD84-3497-43A3-A42F-171DCC1BF1C9Q37954232-816217E3-85F0-456D-A9F0-657345DEFCEDQ37972809-172E9297-9CDB-4DF2-850F-F422559D50C5Q38100667-0EC8223B-1B54-4858-A629-1A169AC1982AQ38219801-0708CC39-ACB1-4FE6-B04A-7F0910260FE5Q38329089-FEECE3AC-97FB-42E6-B953-6D46B54C4A53Q38409403-068254FC-7C4A-49B9-A538-6870360C1F93Q38434362-87E9EF6B-5FC8-42AE-8CA8-9956FB68E2F0Q39013059-F9915073-C6E4-43DA-B98A-75ED016493D8Q48646403-7498B0D1-2A76-4A4B-9EFB-BC7CD553A70EQ50854234-443F611B-3707-43CF-9B64-7E822C712B54Q51594905-5FDA8292-FCE5-4BBA-B23E-B80AF55389F0Q51837330-15C377B5-61E1-4AC3-BF32-48819FF3C4BEQ52982850-534B5C64-9F0B-4016-AB40-26CCC807B896Q53008408-27133A02-602E-4CF0-84DD-8D683D146597Q53112856-7DCC7B3A-7742-4C19-BA0B-F3C113D8AE9FQ53645656-2D74B95D-7337-45A3-A46A-E5C518AD131CQ55010500-0A94BF06-D886-4659-A405-7A7FA7208AB5Q55437783-ED040DDE-AED4-46DA-A7B5-C9823A72F956Q57911034-97AADCC6-E1AB-4922-81ED-67B42E423B94Q58011435-E48FF844-4516-4526-8D16-6EF6C1CCED18
P2860
Cirrhotic rat liver: reference to transporter activity and morphologic changes in bile canaliculi--gadoxetic acid-enhanced MR imaging.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cirrhotic rat liver: reference ...... etic acid-enhanced MR imaging.
@ast
Cirrhotic rat liver: reference ...... etic acid-enhanced MR imaging.
@en
type
label
Cirrhotic rat liver: reference ...... etic acid-enhanced MR imaging.
@ast
Cirrhotic rat liver: reference ...... etic acid-enhanced MR imaging.
@en
prefLabel
Cirrhotic rat liver: reference ...... etic acid-enhanced MR imaging.
@ast
Cirrhotic rat liver: reference ...... etic acid-enhanced MR imaging.
@en
P356
P1433
P1476
Cirrhotic rat liver: reference ...... etic acid-enhanced MR imaging.
@en
P2093
Natsuko Tsuda
Osamu Matsui
P304
P356
10.1148/RADIOL.10092065
P407
P577
2010-07-27T00:00:00Z